These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2800795)

  • 1. [Interferon in the modulation of the immune response in pyelonephritis caused by Staphylococci and Pseudomonas aeruginosa].
    Pavlenko VA; Rudenko AV; Maĭdannik VG; Spivak NIa; Glebova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jun; (6):61-6. PubMed ID: 2800795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of interferon on the course of experimental E coli-induced pyelonephritis].
    Rudenko AV; Maĭdannik VG; Pavlenko VA; Spivak NIa; Romanenko AM; Ishchenko EM; Glebova LP; Bavina EN
    Antibiot Khimioter; 1990 Jan; 35(1):32-5. PubMed ID: 2185709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon inhibition of the development of a staphylococcal infection].
    Zueva VS; Kuznetsov VP; Spivak NIa; Avakian LM
    Antibiot Med Biotekhnol; 1985 Nov; 30(11):863-8. PubMed ID: 4091522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of Pseudomonas aeruginosa pyelonephritis in neutropenic mice with human antilipopolysaccharide monoclonal antibody and cefsulodin.
    Ishibashi K; Yamaguchi O; Shiraiwa Y; Ogihara M; Shigeta S
    J Urol; 1996 Jun; 155(6):2094-7. PubMed ID: 8618343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis].
    Vozianov AF; Kuznetsov VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Fedoruk GV; Drannik GN
    Lik Sprava; 1997; (1):88-92. PubMed ID: 9221157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of alpha/beta and gamma interferon preparations on the functional activity of macrophages in experimental staphylococcal infections].
    Vikhot' NE; Spivak NIa; Chernaia LN; Paster EU
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Apr; (4):57-60. PubMed ID: 2500002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyelonephritic potential of Pseudomonas aeruginosa in ascending mouse model.
    Yadav V; Harjai K; Joshi K; Sharma S
    Indian J Med Res; 2000 Sep; 112():93-9. PubMed ID: 11094854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of cell-mediated immunity in Pseudomonas aeruginosa pyelonephritis: lack of suppressor cell activity in vivo.
    Colizzi V; Campa M; Garzelli C; Toca L; Bevilacqua G; Falcone G
    Med Microbiol Immunol; 1982; 171(3):123-33. PubMed ID: 6219276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of interleukin-10 production in Pseudomonas aeruginosa induced acute pyelonephritis.
    Mittal R; Sharma S; Chhibber S; Harjai K
    J Infect Public Health; 2009; 2(3):136-40. PubMed ID: 20701873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the effect of combination therapy of human granulocyte-colony stimulating factor (G-CSF) and amikacin on experimental pyelonephritis induced by Pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1990 Aug; 64(8):994-1003. PubMed ID: 1698897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the prophylactic and therapeutic effect of human granulocyte-colony stimulating factor (G-CSF) on experimental pyelonephritis induced by pseudomonas aeruginosa in neutropenic mice].
    Tanaka N; Kumamoto Y; Hirose T; Yokoo A
    Kansenshogaku Zasshi; 1989 Feb; 63(2):145-55. PubMed ID: 2473150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of free radicals to Pseudomonas aeruginosa induced acute pyelonephritis.
    Mittal R; Sharma S; Chhibber S; Harjai K
    Microb Pathog; 2008; 45(5-6):323-30. PubMed ID: 18771720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effects of anti-OEP-antibodies in the Pseudomonas aeruginosa (Fisher's seven serotypes) infection of mice and the influence of this antibody upon the phagocytic activity of mice spleen macrophages (author's transl)].
    Haranaka K; Satomi N; Matsuo M; Kunii O; Mashimo K
    Kansenshogaku Zasshi; 1979 Apr; 53(4):175-81. PubMed ID: 89175
    [No Abstract]   [Full Text] [Related]  

  • 14. Depletion of natural killer cells increases mice susceptibility in a Pseudomonas aeruginosa pneumonia model.
    Broquet A; Roquilly A; Jacqueline C; Potel G; Caillon J; Asehnoune K
    Crit Care Med; 2014 Jun; 42(6):e441-50. PubMed ID: 24732238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitoxic effect of leukocytic interferon in in vivo experiments].
    Babaiants AA; Karganova GG
    Antibiotiki; 1984 Nov; 29(11):834-6. PubMed ID: 6524883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of granulocyte colony-stimulating factor (G-CSF) in a granulocytopenic mouse model of Pseudomonas aeruginosa lung infection through enhanced phagocytosis and killing by alveolar macrophages through priming tumour necrosis factor-alpha (TNF-alpha) production.
    Shirai R; Kadota J; Tomono K; Ogawa K; Iida K; Kawakami K; Kohno S
    Clin Exp Immunol; 1997 Jul; 109(1):73-9. PubMed ID: 9218827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of active and passive immunization on the development of experimental Pseudomonas aeruginosa pyelonephritis in mice.
    Petit JC; Sicard D; Bayo S; Daguet GL
    Can J Microbiol; 1981 Jan; 27(1):93-7. PubMed ID: 6783287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukinferon in the combined therapy of infection in neonates and infants].
    Nizharadze GI; Kuznetsov VP; Gamkhitashvili ASh; Chitaishvili KG; Pavlenishvili IV
    Pediatriia; 1989; (6):46-9. PubMed ID: 2668867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EXPERIMENTAL PYELONEPHRITIS IN THE MOUSE PRODUCED BY ESCHERICHIA COLI, PSEUDOMONAS AERUGINOSA AND PROTEUS MIRABILIS.
    GORRILL RH; DENAVASQUEZ SJ
    J Pathol Bacteriol; 1964 Jan; 87():79-87. PubMed ID: 14106358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Characteristics of the increased resistance of mice to Pseudomonas aeruginosa caused by Staphylococcus aureus].
    Mathieu LG; deRepentigny J; Gadbois T
    Can J Microbiol; 1976 Dec; 22(12):1734-42. PubMed ID: 827329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.